HM
EUCRU

HealthCor Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

HealthCor Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-234,180
Closed -$2.32M – 92
2021
Q3 		$2.32M Hold
234,180
– – 0.1% 57
2021
Q2 		$2.39M Sell
234,180
-100,000
-30% -$1M 0.1% 59
2021
Q1 		$3.36M Buy
+334,180
New +$3.56M 0.12% 69

Other funds holding EUCRU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

HealthCor Management's EUCRU Position: Q4 2021 in Review

HealthCor Management sold out of Eucrates Biomedical Acquisition Corp. Unit (EUCRU) in Q4 2021, closing a stake of 234,180 shares — an estimated $2.32M sold.

HealthCor Management first reported a position in EUCRU in Q1 2021 and held it in 3 quarters. The position peaked at $3.36M in Q1 2021. 14 funds tracked by Wall St. Rank hold EUCRU as of Q4 2021.

  • HealthCor Management reported no remaining Eucrates Biomedical Acquisition Corp. Unit position as of Q4 2021 after selling out during the quarter.
  • HealthCor Management sold 234,180 Eucrates Biomedical Acquisition Corp. Unit shares in Q4 2021, an estimated $2.32M.
  • HealthCor Management first reported a position in Eucrates Biomedical Acquisition Corp. Unit in Q1 2021 and held it in 3 quarters.
  • HealthCor Management's Eucrates Biomedical Acquisition Corp. Unit position peaked at $3.36M in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Unit as of Q4 2021.

Based on HealthCor Management's 13F filing for Q4 2021, filed 14 Feb 2022.